Oxford Finance LLC

Oxford Finance is a specialty finance firm headquartered in Alexandria, Virginia, that provides venture debt and enterprise lending to high-growth life sciences and healthtech companies. It is not an equity investor — founders should think of Oxford as a non-dilutive complement to an existing equity round rather than a lead investor. AI is not the focus; the firm underwrites borrowers based on revenue, equity backing, and runway extension needs, regardless of whether the underlying product is software, device, or therapeutic.

Oxford lends to companies at growth, Series C, and Series D+ stages with deal sizes of $25M and above. That positions the firm for sizeable working-capital, runway-extension, or acquisition-financing facilities for venture-backed companies that have already raised meaningful equity.

Founders should approach Oxford Finance when they have closed a credible equity round, have visibility into revenue or clinical milestones, and want to extend runway or fund a specific use case without further dilution. Early-stage companies without institutional equity backing or a clear repayment thesis will not qualify. Expect underwriting that looks more like a bank than a VC — financial covenants, warrants, and a structured term sheet. Use Oxford as a tool inside a broader capital plan: it is most powerful when paired with a recent equity round and a defined milestone the debt is designed to reach. Pricing and structure are negotiable and worth scrutiny.